Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 218

1.

The rat-based neurovirulence safety test for the assessment of mumps virus neurovirulence in humans: an international collaborative study.

Rubin SA, Afzal MA, Powell CL, Bentley ML, Auda GR, Taffs RE, Carbone KM.

J Infect Dis. 2005 Apr 1;191(7):1123-8. Epub 2005 Feb 22.

PMID:
15747248
2.

The mumps virus neurovirulence safety test in Rhesus monkeys: a comparison of mumps virus strains.

Rubin SA, Snoy PJ, Wright KE, Brown EG, Reeve P, Beeler JA, Carbone KM.

J Infect Dis. 1999 Aug;180(2):521-5.

PMID:
10395874
3.

Neurovirulence safety testing of mumps vaccines--historical perspective and current status.

Rubin SA, Afzal MA.

Vaccine. 2011 Apr 5;29(16):2850-5. doi: 10.1016/j.vaccine.2011.02.005. Epub 2011 Feb 18. Review.

PMID:
21334386
4.

[Comparative evaluation of Leningrad-3 mumps vaccine virus neurovirulence in a neonatal rat model].

Ignat'ev GM, Otrashevskaia EV, Rubin SA.

Vopr Virusol. 2011 Jul-Aug;56(4):30-3. Russian.

PMID:
21899067
5.

Neurovirulence of mumps virus: intraspinal inoculation test in marmosets.

Saika S, Kidokoro M, Aoki A, Ohkawa T.

Biologicals. 2004 Sep;32(3):147-52.

PMID:
15536045
6.

Changes in mumps virus gene sequence associated with variability in neurovirulent phenotype.

Rubin SA, Amexis G, Pletnikov M, Li Z, Vanderzanden J, Mauldin J, Sauder C, Malik T, Chumakov K, Carbone KM.

J Virol. 2003 Nov;77(21):11616-24. Erratum in: J Virol. 2003 Dec;77(24):13456. J Virol. 2007 Aug;81(16):8849.

7.

Evaluation of the neurovirulence test for mumps vaccines.

Afzal MA, Marsden SA, Hull RM, Pipkin PA, Bentley ML, Minor PD.

Biologicals. 1999 Mar;27(1):43-9.

PMID:
10441402
8.
9.
10.

[Unsuitability of the neurovirulence test for assessing the safety of vaccinal strains of the mumps virus].

Smorodintsev AA.

Tr Inst Im Pastera. 1979;53:101-3. Russian. No abstract available.

PMID:
262708
11.

Monkey neurovirulence test for live mumps vaccine.

Maximova O, Dragunsky E, Taffs R, Snoy P, Cogan J, Marsden S, Levenbook I.

Biologicals. 1996 Sep;24(3):223-4. No abstract available.

PMID:
8978921
12.

Changes in mumps virus neurovirulence phenotype associated with quasispecies heterogeneity.

Sauder CJ, Vandenburgh KM, Iskow RC, Malik T, Carbone KM, Rubin SA.

Virology. 2006 Jun 20;350(1):48-57. Epub 2006 Feb 21.

13.

Presence of lysine at aa 335 of the hemagglutinin-neuraminidase protein of mumps virus vaccine strain Urabe AM9 is not a requirement for neurovirulence.

Sauder CJ, Zhang CX, Link MA, Duprex WP, Carbone KM, Rubin SA.

Vaccine. 2009 Sep 25;27(42):5822-9. doi: 10.1016/j.vaccine.2009.07.051. Epub 2009 Aug 4.

PMID:
19660591
14.

Safety of live mumps virus vaccines.

Furesz J.

J Med Virol. 2002 Jul;67(3):299-300. No abstract available.

PMID:
12116018
15.

Identification of genetic mutations associated with attenuation and changes in tropism of Urabe mumps virus.

Shah D, Vidal S, Link MA, Rubin SA, Wright KE.

J Med Virol. 2009 Jan;81(1):130-8. doi: 10.1002/jmv.21381.

PMID:
19031463
16.

Influence of population diversity on neurovirulence potential of plaque purified L-Zagreb variants.

Ivancic-Jelecki J, Forcic D, Jagusic M, Kosutic-Gulija T, Mazuran R, Balija ML, Isakov O, Shomron N.

Vaccine. 2016 Apr 29;34(20):2383-9. doi: 10.1016/j.vaccine.2016.03.033. Epub 2016 Mar 21.

PMID:
27013432
17.

Gene-specific contributions to mumps virus neurovirulence and neuroattenuation.

Sauder CJ, Zhang CX, Ngo L, Werner K, Lemon K, Duprex WP, Malik T, Carbone K, Rubin SA.

J Virol. 2011 Jul;85(14):7059-69. doi: 10.1128/JVI.00245-11. Epub 2011 May 4.

18.

Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys.

Monath TP, Myers GA, Beck RA, Knauber M, Scappaticci K, Pullano T, Archambault WT, Catalan J, Miller C, Zhang ZX, Shin S, Pugachev K, Draper K, Levenbook IS, Guirakhoo F.

Biologicals. 2005 Sep;33(3):131-44.

PMID:
15975826
19.

Pathogenicity of mumps virus in the marmoset.

Saika S, Kidokoro M, Ohkawa T, Aoki A, Suzuki K.

J Med Virol. 2002 Jan;66(1):115-22.

PMID:
11748667
20.

Supplemental Content

Support Center